Steven Cohen Deciphera Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $4.97 Million - $8.13 Million	-491,278 Reduced 82.14%	106,800 $1.72 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $260,015 - $323,036	-20,868 Reduced 3.37%	598,078 $7.61 Million
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $7.24 Million - $8.7 Million	544,995 Added 736.97%	618,946 $8.71 Million
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $1.05 Million - $1.63 Million	73,951 New	73,951 $1.14 Million
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $392,130 - $1.89 Million	-50,926 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $3.05 Million - $4.28 Million	-115,174 Reduced 69.34%	50,926 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$32.73 - $47.95 $5.44 Million - $7.96 Million	166,100 New	166,100 $6.08 Million
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $6.11 Million - $12.6 Million	-181,680 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$31.7 - $69.93 $4.26 Million - $9.4 Million	-134,421 Reduced 42.52%	181,680 $11.3 Million
Q3 2019 Nov 15, 2019	BUY	$19.95 - $38.85 $2.23 Million - $4.34 Million	111,827 Added 54.74%	316,101 $10.7 Million
Q2 2019 Aug 14, 2019	BUY	$21.05 - $26.21 $4.3 Million - $5.35 Million	204,274 New	204,274 $4.61 Million
Q1 2019 May 15, 2019	SELL	$20.65 - $29.55 $6.2 Million - $8.87 Million	-300,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$19.08 - $36.14 $5.72 Million - $10.8 Million	300,000 New	300,000 $6.3 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.